123 related articles for article (PubMed ID: 37104657)
1. Hematological and Other Cancers in People Using Clozapine: Analysis of Australian Spontaneous Reports Between 1995 and 2020.
Dawson JL; Sluggett JK; Procter NG; Myles N; Bell JS
J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):333-338. PubMed ID: 37104657
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
3. Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003.
Haas SJ; Hill R; Krum H; Liew D; Tonkin A; Demos L; Stephan K; McNeil J
Drug Saf; 2007; 30(1):47-57. PubMed ID: 17194170
[TBL] [Abstract][Full Text] [Related]
4. Haematologic malignancies associated with clozapine
Chrétien B; Lelong-Boulouard V; Chantepie S; Sassier M; Bertho M; Brazo P; Humbert X; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jul; 51(9):1459-1466. PubMed ID: 32036793
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Clozapine and Non-Hematological Malignant Tumors: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System Database.
Uwai Y; Nabekura T
Drugs Real World Outcomes; 2024 Apr; ():. PubMed ID: 38556566
[TBL] [Abstract][Full Text] [Related]
6. Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis.
Siskind DJ; Harris M; Phillipou A; Morgan VA; Waterreus A; Galletly C; Carr VJ; Harvey C; Castle D
Epidemiol Psychiatr Sci; 2017 Jun; 26(3):325-337. PubMed ID: 27426892
[TBL] [Abstract][Full Text] [Related]
7. Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.
Every-Palmer S; Ellis PM
CNS Drugs; 2017 Aug; 31(8):699-709. PubMed ID: 28623627
[TBL] [Abstract][Full Text] [Related]
8. Hematological and cardiometabolic safety of clozapine in the treatment of very early onset schizophrenia: a retrospective chart review.
Midbari Y; Ebert T; Kosov I; Kotler M; Weizman A; Ram A
J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):516-21. PubMed ID: 24111981
[TBL] [Abstract][Full Text] [Related]
9. Exploring the potential effect of polypharmacy on the hematologic profiles of clozapine patients.
Shuman MD; Trigoboff E; Demler TL; Opler LA
J Psychiatr Pract; 2014 Jan; 20(1):50-8. PubMed ID: 24419309
[TBL] [Abstract][Full Text] [Related]
10. Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Polcwiartek C; Vang T; Bruhn CH; Hashemi N; Rosenzweig M; Nielsen J
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3663-3672. PubMed ID: 27592232
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls.
Ronaldson KJ; Taylor AJ; Fitzgerald PB; Topliss DJ; Elsik M; McNeil JJ
J Clin Psychiatry; 2010 Aug; 71(8):976-81. PubMed ID: 20361910
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Clozapine Use and Safety by Using Comprehensive National Data From the Japanese Clozapine Patient Monitoring Service.
Inada K; Oshibuchi H; Ishigooka J; Nishimura K
J Clin Psychopharmacol; 2018 Aug; 38(4):302-306. PubMed ID: 29912802
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of a randomized switch of patients from clozaril to generic clozapine.
Kluznik JC; Walbek NH; Farnsworth MG; Melstrom K
J Clin Psychiatry; 2001; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study.
Lee J; Takeuchi H; Fervaha G; Powell V; Bhaloo A; Bies R; Remington G
J Clin Psychopharmacol; 2015 Oct; 35(5):510-6. PubMed ID: 26267420
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
18. Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom.
Wheeler AJ; Feetam CL; Harrison J
Clin Drug Investig; 2014 Mar; 34(3):203-11. PubMed ID: 24402882
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
[TBL] [Abstract][Full Text] [Related]
20. Rates and Reasons for Clozapine Treatment Interruptions: Impact of the Frequency of Hematologic Monitoring and Cardiac Adverse Events.
John AP; Stanley S; Haywood D
J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):233-238. PubMed ID: 37126829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
